AR and metastatic prostate carcinoma: On the basis of our findings, we envision that the strategy of radiation plus AR signaling inhibition (leading to IKKE upregulation) could be effective in treatment-naive metastatic prostate cancer and that radiation in combination with an AR degrader could be one of the viable options.